Literature DB >> 31632564

Nobiletin alleviates cerebral ischemic-reperfusion injury via MAPK signaling pathway.

Tao Wang1, Feng Wang1, Lu Yu1, Zaiwang Li1.   

Abstract

BACKGROUND: Nobiletin (NOB), isolated from Citrus nobilis, has been reported to inhibit cerebral ischemia/reperfusion (I/R) induced cell apoptosis in the brain. The mechanisms and the protective ability of NOB on cerebral I/R rats are unclear.
METHODS: A middle cerebral artery occlusion (MCAO) rat model was established and treated with different doses of NOB. The neurological deficits, brain water content and brain index were explored after reperfusion, and TTC staining was applied to assess the infarct area. The production of reactive oxygen species (ROS) related enzymes in the ischemic cortex samples from each group was measured. TUNEL staining was performed to evaluate neuronal cell apoptosis in brain tissues. The expression of cell apoptosis related proteins, p-p38 and MAPKAP-2 and the levels of inflammatory factors were examined by western blotting assay and ELISA.
RESULTS: NOB treatment notably improved the neurological deficits, brain water content and brain index in an MCAO model, accompanied by decreased infarct area in the brain tissue. Apoptosis induced by cerebral I/R was also decreased by NOB administration via upregulating Bcl-2 and downregulating Bax and caspase3. The levels of pro-inflammatory mediators TNF-α, IL-6 were reduced and anti-inflammatory cytokine IL-10 was increased by NOB treatment in MCAO rats. Further, we found that the expression of p-p38 and MAPKAP-2 was reduced by NOB treatment in MCAO rats.
CONCLUSION: The present results suggest that NOB serves a protective role in I/R-induced cerebral-neuron injury. The mechanisms underlying these effects may be associated with the MAPK signaling pathway. AJTR
Copyright © 2019.

Entities:  

Keywords:  MAPKAP-2; Nobiletin; apoptosis; ischemic-reperfusion injury; middle cerebral artery occlusion; p38

Year:  2019        PMID: 31632564      PMCID: PMC6789284     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  42 in total

Review 1.  Mitochondrial mechanisms of neural cell apoptosis.

Authors:  Brian M Polster; Gary Fiskum
Journal:  J Neurochem       Date:  2004-09       Impact factor: 5.372

2.  Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation.

Authors:  Xia Xue; Xian-Jun Qu; Ying Yang; Xie-Huang Sheng; Fang Cheng; E-Nang Jiang; Jian-hua Wang; Wen Bu; Zhao-Ping Liu
Journal:  Biochem Biophys Res Commun       Date:  2010-11-17       Impact factor: 3.575

3.  PUMA mediates the apoptotic signal of hypoxia/reoxygenation in cardiomyocytes through mitochondrial pathway.

Authors:  Yuzhen Li; Xiuhua Liu; Fei Rong
Journal:  Shock       Date:  2011-06       Impact factor: 3.454

Review 4.  Pathophysiology of ischaemia-reperfusion injury.

Authors:  D L Carden; D N Granger
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

Review 5.  Mitochondria in neuroplasticity and neurological disorders.

Authors:  Mark P Mattson; Marc Gleichmann; Aiwu Cheng
Journal:  Neuron       Date:  2008-12-10       Impact factor: 17.173

6.  Neuroprotective effect of nobiletin on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats.

Authors:  Nodoka Yasuda; Takayuki Ishii; Dai Oyama; Tatsuya Fukuta; Yurika Agato; Akihiko Sato; Kosuke Shimizu; Tomohiro Asai; Tomohiro Asakawa; Toshiyuki Kan; Shizuo Yamada; Yasushi Ohizumi; Naoto Oku
Journal:  Brain Res       Date:  2014-02-15       Impact factor: 3.252

7.  Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat.

Authors:  Lan Zhang; Huiying Zhao; Xiangjian Zhang; Linyu Chen; Xumeng Zhao; Xue Bai; Jian Zhang
Journal:  Brain Res Bull       Date:  2013-05-02       Impact factor: 4.077

8.  A novel activation pathway for mature thymocytes. Costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation.

Authors:  S Y Yang; S M Denning; S Mizuno; B Dupont; B F Haynes
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

9.  Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.

Authors:  Nipin Sp; Dong Young Kang; Youn Hee Joung; Jong Hwan Park; Wan Seop Kim; Hak Kyo Lee; Ki-Duk Song; Yeong-Min Park; Young Mok Yang
Journal:  Int J Mol Sci       Date:  2017-04-30       Impact factor: 5.923

10.  Neuroglobin boosts axon regeneration during ischemic reperfusion via p38 binding and activation depending on oxygen signal.

Authors:  Xin Xin Xiong; Feng Pan; Ruo Qiao Chen; Dian Xing Hu; Xin Yao Qiu; Chun Yang Li; Xiao Qiang Xie; Bo Tian; Xiao Qian Chen
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

View more
  11 in total

1.  Nobiletin prevents amyloid β1-40-induced cognitive impairment via inhibition of neuroinflammation and oxidative/nitrosative stress.

Authors:  Reihaneh Ghasemi-Tarie; Zahra Kiasalari; Marzieh Fakour; Maryam Khorasani; Sedigheh Keshtkar; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Metab Brain Dis       Date:  2022-03-16       Impact factor: 3.655

2.  Nobiletin Inhibits Hypoxia-Induced Placental Damage via Modulating P53 Signaling Pathway.

Authors:  Meng-Ling Zhang; Qian Yang; Yan-Di Zhu; Ya-Di Zhang; Rui Zhang; Jian Liu; Xiao-Yan Zhao; Qin-Yu Dang; Dong-Xu Huang; Ming-Yuan Zhang; Yu-Chen Wei; Zhuo Hu; Xia-Xia Cai; Li-Fang Gao; Yang Shan; Huan-Ling Yu
Journal:  Nutrients       Date:  2022-06-01       Impact factor: 6.706

Review 3.  The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke.

Authors:  Xing-Hua Li; Feng-Ting Yin; Xiao-Hang Zhou; Ai-Hua Zhang; Hui Sun; Guang-Li Yan; Xi-Jun Wang
Journal:  Molecules       Date:  2022-05-12       Impact factor: 4.927

Review 4.  Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sedigheh Saberifar; Farid Hashemi; Kiavash Hushmandi; Fardin Hashemi; Ebrahim Rahmani Moghadam; Reza Mohammadinejad; Masoud Najafi; Manoj Garg
Journal:  Biomedicines       Date:  2020-05-05

Review 5.  Beneficial Effects of Citrus-Derived Polymethoxylated Flavones for Central Nervous System Disorders.

Authors:  Kentaro Matsuzaki; Yasushi Ohizumi
Journal:  Nutrients       Date:  2021-01-04       Impact factor: 5.717

6.  Adenosine A2A receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway.

Authors:  Il-Gyu Ko; Jun-Jang Jin; Lakkyong Hwang; Sang-Hoon Kim; Chang-Ju Kim; Jung Won Jeon; Jun-Young Chung; Jin Hee Han
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

7.  Nobiletin ameliorates cardiac impairment and alleviates cardiac remodeling after acute myocardial infarction in rats via JNK regulation.

Authors:  Zumei Liu; Zhimin Gao; Lihuan Zeng; Zhenye Liang; Dechong Zheng; Xiaoqian Wu
Journal:  Pharmacol Res Perspect       Date:  2021-04

Review 8.  Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review).

Authors:  Xiaolu Zhang; Wenyun Zeng; Yue Zhang; Qun Yu; Miao Zeng; Jiali Gan; Wenlan Zhang; Xijuan Jiang; Huhu Li
Journal:  Int J Mol Med       Date:  2022-04-08       Impact factor: 5.314

Review 9.  The Application of Citrus folium in Breast Cancer and the Mechanism of Its Main Component Nobiletin: A Systematic Review.

Authors:  Yuan Wu; Chien-Shan Cheng; Qiong Li; Jing-Xian Chen; Ling-Ling Lv; Jia-Yue Xu; Kai-Yuan Zhang; Lan Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-29       Impact factor: 2.629

10.  Nobiletin alleviates ischemia/reperfusion injury in the kidney by activating PI3K/AKT pathway.

Authors:  Bo Liu; Quanhong Deng; Lei Zhang; Wen Zhu
Journal:  Mol Med Rep       Date:  2020-10-01       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.